This patient did not present with polyposis and suggests that there may be additional cases with biallelic pathogenic MSH3 germline variants without severe polyposis as a clinical presentation, and MSH3 analysis should be considered in all individuals with early-onset colorectal cancer. This evidence concerns the gene MSH3 and colorectal cancer.